智通财经APP获悉,近日,美国加利福尼亚大学洛杉矶分校(UCLA)免疫遗传中心2024年室间质评结果公布。上海信诺佰世参评的HLA高分辨基因分型,MICA基因高分辨分型,HLA抗体检测和KIR基因分型均以S级的满分成绩通过。证明上海信诺佰世具有良好的结果溯源性和严格的质量管理,检验结果得到国际权威认可。
HLA高分辨基因分型
MICA基因高分辨分型
HLA抗体检测
KIR基因分型
此次满分通过UCLA国际室间质评,充分证明了上海信诺佰世在造血干细胞移植相关检测技术领域得到国际权威认可。上海信诺佰世围绕移植诊疗的全流程,开展多项移植板块相关检测项目,为移植患者提供更全面的服务,助力临床医生为移植患者提供全生命周期的疾病管理和风险控制。
更多港股重磅资讯,下载智通财经app
更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.